Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BA 1301

Next Previous
Drug Profile

BA 1301

Alternative Names: BA-1301; Claudin 18.2 ADC - Shandong Boan Biotechnology; PR-301

Latest Information Update: 14 Jul 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shandong Boan Biotechnology
  • Class Antibodies; Antineoplastics; Auristatins; Drug conjugates; Immunoconjugates; Immunotoxins
  • Mechanism of Action Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pancreatic cancer; Gastric cancer
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Cervical cancer; Cholangiocarcinoma; Gastric cancer; Ovarian cancer
  • Phase I Solid tumours

Most Recent Events

  • 14 Jul 2026 Phase-I/II clinical trials in Cholangiocarcinoma in China (IV), prior to July 2026 (Luye Pharma Group pipeline, July 2026)
  • 14 Jul 2026 Phase-I/II clinical trials in Gastric cancer in China (IV), prior to July 2026 (Luye Pharma Group pipeline, July 2026)
  • 14 Jul 2026 Phase-I/II clinical trials in Ovarian cancer in China (IV), prior to July 2026 (Luye Pharma Group pipeline, July 2026)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top